Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1951 2
1952 1
1954 5
1965 1
1994 1
2014 1
2017 1
2018 1
2019 1
2020 2
2021 2
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
Dangas GD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, De Backer O, Guimarães AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Seeger J, Tchétché D, Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P, Volkl AA, Zazula A, van Amsterdam RGM, Mehran R, Windecker S; GALILEO Investigators. Dangas GD, et al. N Engl J Med. 2020 Jan 9;382(2):120-129. doi: 10.1056/NEJMoa1911425. Epub 2019 Nov 16. N Engl J Med. 2020. PMID: 31733180 Free article. Clinical Trial.
[Experiences with polydyn].
WESSELY EA. WESSELY EA. Wien Med Wochenschr. 1952 Sep 13;102(37):727-9. Wien Med Wochenschr. 1952. PMID: 13006305 Undetermined Language. No abstract available.
Hemodynamics during ventricular tachyarrhythmias.
Steinbach KK, Merl O, Frohner K, Hief C, Nürnberg M, Kaltenbrunner W, Podczeck A, Wessely E. Steinbach KK, et al. Among authors: wessely e. Am Heart J. 1994 Apr;127(4 Pt 2):1102-6. doi: 10.1016/0002-8703(94)90095-7. Am Heart J. 1994. PMID: 8160588
Impact of On-Site Cardiac Surgery on Clinical Outcomes After Transfemoral Transcatheter Aortic Valve Replacement.
Egger F, Zweiker D, Freynhofer MK, Löffler V, Rohla M, Geppert A, Farhan S, Vogel B, Falkensammer J, Kastner J, Pichler P, Vock P, Lamm G, Luha O, Schmidt A, Scherr D, Hammerer M, Hoppe UC, Maurer E, Grund M, Lambert T, Tkalec W, Sturmberger T, Zeindlhofer E, Grabenwöger M, Huber K; Austrian TAVI Group. Egger F, et al. JACC Cardiovasc Interv. 2018 Nov 12;11(21):2160-2167. doi: 10.1016/j.jcin.2018.07.015. JACC Cardiovasc Interv. 2018. PMID: 30409272 Free article.
Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes.
Tentzeris I, Rohla M, Jarai R, Farhan S, Freynhofer MK, Unger G, Nürnberg M, Geppert A, Wessely E, Wojta J, Huber K. Tentzeris I, et al. Among authors: wessely e. Am J Cardiol. 2014 Apr 1;113(7):1099-104. doi: 10.1016/j.amjcard.2013.12.012. Epub 2014 Jan 14. Am J Cardiol. 2014. PMID: 24462073 Clinical Trial.
[Carcinosarcoma of the larynx].
WESSELY EA. WESSELY EA. Wien Med Wochenschr. 1951 Sep 1-8;101(35-36):675-6. Wien Med Wochenschr. 1951. PMID: 14884537 Undetermined Language. No abstract available.
Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
Tentzeris I, Farhan S, Freynhofer MK, Rohla M, Jarai R, Vogel B, Baumgartner-Parzer S, Nürnberg M, Geppert A, Wessely E, Wojta J, Huber K, Kautzky-Willer A. Tentzeris I, et al. Among authors: wessely e. Am J Cardiol. 2017 Sep 1;120(5):747-752. doi: 10.1016/j.amjcard.2017.05.045. Epub 2017 Jun 15. Am J Cardiol. 2017. PMID: 28734463
19 results